FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2796374194> ?p ?o ?g. }

• W2796374194 endingPage "e0006376" @default.
• W2796374194 startingPage "e0006376" @default.
• W2796374194 abstract "Background Cholera is an acute voluminous dehydrating diarrheal disease caused by toxigenic strains of Vibrio cholerae O1 and occasionally O139. A growing body of evidence indicates that immune responses targeting the O-specific polysaccharide (OSP) of V. cholerae are involved in mediating protection against cholera. We therefore assessed whether antibody responses against OSP occur after vaccination with live attenuated oral cholera vaccine CVD 103-HgR, and whether such responses correlate with protection against cholera. Methodology We assessed adult North American volunteers (n = 46) who were vaccinated with 5 × 108 colony-forming units (CFU) of oral cholera vaccine CVD 103-HgR and then orally challenged with approximately 1 × 105 CFU of wild-type V. cholerae O1 El Tor Inaba strain N16961, either 10 or 90 days post-vaccination. Principal findings Vaccination was associated with induction of significant serum IgM and IgA anti-OSP and vibriocidal antibody responses within 10 days of vaccination. There was significant correlation between anti-OSP and vibriocidal antibody responses. IgM and IgA anti-OSP responses on day 10 following vaccination were associated with lower post-challenge stool volume (r = −0.44, P = 0.002; r = −0.36, P = 0.01; respectively), and none of 27 vaccinees who developed a ≥1.5 fold increase in any antibody isotype targeting OSP on day 10 following vaccination compared to baseline developed moderate or severe cholera following experimental challenge, while 5 of 19 who did not develop such anti-OSP responses did (P = 0.01). Conclusion Oral vaccination with live attenuated cholera vaccine CVD 103-HgR induces antibodies that target V. cholerae OSP, and these anti-OSP responses correlate with protection against diarrhea following experimental challenge with V. cholerae O1. Trial registration ClinicalTrials.gov NCT01895855" @default.
• W2796374194 created "2018-04-13" @default.
• W2796374194 creator A5001360183 @default.
• W2796374194 creator A5001374764 @default.
• W2796374194 creator A5010472783 @default.
• W2796374194 creator A5014624716 @default.
• W2796374194 creator A5016479802 @default.
• W2796374194 creator A5018767435 @default.
• W2796374194 creator A5021173085 @default.
• W2796374194 creator A5039650840 @default.
• W2796374194 creator A5044687965 @default.
• W2796374194 creator A5047645117 @default.
• W2796374194 creator A5048007285 @default.
• W2796374194 creator A5048166533 @default.
• W2796374194 creator A5049145301 @default.
• W2796374194 creator A5052410990 @default.
• W2796374194 creator A5065532410 @default.
• W2796374194 creator A5068464752 @default.
• W2796374194 creator A5074465314 @default.
• W2796374194 creator A5081650390 @default.
• W2796374194 creator A5084859141 @default.
• W2796374194 creator A5084984665 @default.
• W2796374194 creator A5087337307 @default.
• W2796374194 creator A5087845014 @default.
• W2796374194 date "2018-04-06" @default.
• W2796374194 modified "2023-10-18" @default.
• W2796374194 title "Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers" @default.
• W2796374194 cites W1907758307 @default.
• W2796374194 cites W1931041578 @default.
• W2796374194 cites W1962650323 @default.
• W2796374194 cites W2006761088 @default.
• W2796374194 cites W2053452202 @default.
• W2796374194 cites W2077127045 @default.
• W2796374194 cites W2092415903 @default.
• W2796374194 cites W2103873606 @default.
• W2796374194 cites W2109467642 @default.
• W2796374194 cites W2109885373 @default.
• W2796374194 cites W2113523267 @default.
• W2796374194 cites W2116932169 @default.
• W2796374194 cites W2121456197 @default.
• W2796374194 cites W2125072226 @default.
• W2796374194 cites W2126901488 @default.
• W2796374194 cites W2132341147 @default.
• W2796374194 cites W2135059394 @default.
• W2796374194 cites W2139654401 @default.
• W2796374194 cites W2145879362 @default.
• W2796374194 cites W2147699573 @default.
• W2796374194 cites W2150863194 @default.
• W2796374194 cites W2154441406 @default.
• W2796374194 cites W2156874418 @default.
• W2796374194 cites W2166880878 @default.
• W2796374194 cites W2309663145 @default.
• W2796374194 cites W2321882843 @default.
• W2796374194 cites W2395257209 @default.
• W2796374194 cites W4211176329 @default.
• W2796374194 cites W4233722678 @default.
• W2796374194 cites W818949034 @default.
• W2796374194 doi "https://doi.org/10.1371/journal.pntd.0006376" @default.
• W2796374194 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5906022" @default.
• W2796374194 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29624592" @default.
• W2796374194 hasPublicationYear "2018" @default.
• W2796374194 type Work @default.
• W2796374194 sameAs 2796374194 @default.
• W2796374194 citedByCount "25" @default.
• W2796374194 countsByYear W27963741942018 @default.
• W2796374194 countsByYear W27963741942019 @default.
• W2796374194 countsByYear W27963741942020 @default.
• W2796374194 countsByYear W27963741942021 @default.
• W2796374194 countsByYear W27963741942022 @default.
• W2796374194 crossrefType "journal-article" @default.
• W2796374194 hasAuthorship W2796374194A5001360183 @default.
• W2796374194 hasAuthorship W2796374194A5001374764 @default.
• W2796374194 hasAuthorship W2796374194A5010472783 @default.
• W2796374194 hasAuthorship W2796374194A5014624716 @default.
• W2796374194 hasAuthorship W2796374194A5016479802 @default.
• W2796374194 hasAuthorship W2796374194A5018767435 @default.
• W2796374194 hasAuthorship W2796374194A5021173085 @default.
• W2796374194 hasAuthorship W2796374194A5039650840 @default.
• W2796374194 hasAuthorship W2796374194A5044687965 @default.
• W2796374194 hasAuthorship W2796374194A5047645117 @default.
• W2796374194 hasAuthorship W2796374194A5048007285 @default.
• W2796374194 hasAuthorship W2796374194A5048166533 @default.
• W2796374194 hasAuthorship W2796374194A5049145301 @default.
• W2796374194 hasAuthorship W2796374194A5052410990 @default.
• W2796374194 hasAuthorship W2796374194A5065532410 @default.
• W2796374194 hasAuthorship W2796374194A5068464752 @default.
• W2796374194 hasAuthorship W2796374194A5074465314 @default.
• W2796374194 hasAuthorship W2796374194A5081650390 @default.
• W2796374194 hasAuthorship W2796374194A5084859141 @default.
• W2796374194 hasAuthorship W2796374194A5084984665 @default.
• W2796374194 hasAuthorship W2796374194A5087337307 @default.
• W2796374194 hasAuthorship W2796374194A5087845014 @default.
• W2796374194 hasBestOaLocation W27963741941 @default.
• W2796374194 hasConcept C159047783 @default.
• W2796374194 hasConcept C159654299 @default.
• W2796374194 hasConcept C203014093 @default.
• W2796374194 hasConcept C22070199 @default.
• W2796374194 hasConcept C2777006276 @default.

• next